BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15100294)

  • 21. FOXO3a/p27kip1 expression and essential role after acute spinal cord injury in adult rat.
    Zhang S; Huan W; Wei H; Shi J; Fan J; Zhao J; Shen A; Teng H
    J Cell Biochem; 2013 Feb; 114(2):354-65. PubMed ID: 22930444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental chemical-induced pro/pre-B cell apoptosis: analysis of c-Myc, p27Kip1, and p21WAF1 reveals a death pathway distinct from clonal deletion.
    Ryu HY; Mann KK; Schlezinger JJ; Jensen B; Sherr DH
    J Immunol; 2003 May; 170(10):4897-904. PubMed ID: 12734332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1.
    Shi J; Zhang L; Shen A; Zhang J; Wang Y; Zhao Y; Zou L; Ke Q; He F; Wang P; Cheng C; Shi G
    J Neurooncol; 2010 May; 98(1):57-69. PubMed ID: 19911116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FLT3 ligand regulates apoptosis through AKT-dependent inactivation of transcription factor FoxO3.
    Jönsson M; Engström M; Jönsson JI
    Biochem Biophys Res Commun; 2004 Jun; 318(4):899-903. PubMed ID: 15147956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
    Murillo H; Huang H; Schmidt LJ; Smith DI; Tindall DJ
    Endocrinology; 2001 Nov; 142(11):4795-805. PubMed ID: 11606446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1).
    Nakao T; Geddis AE; Fox NE; Kaushansky K
    Cell Cycle; 2008 Jan; 7(2):257-66. PubMed ID: 18256550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression.
    Katayama K; Nakamura A; Sugimoto Y; Tsuruo T; Fujita N
    Oncogene; 2008 Mar; 27(12):1677-86. PubMed ID: 17873901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.
    Brennan P; Babbage JW; Burgering BM; Groner B; Reif K; Cantrell DA
    Immunity; 1997 Nov; 7(5):679-89. PubMed ID: 9390691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.
    Kops GJ; Medema RH; Glassford J; Essers MA; Dijkers PF; Coffer PJ; Lam EW; Burgering BM
    Mol Cell Biol; 2002 Apr; 22(7):2025-36. PubMed ID: 11884591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
    Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of c-myc and p27 in anti-IgM induced B-lymphoma apoptosis.
    Scott DW; Donjerković D; Maddox B; Ezhevsky S; Grdina T
    Curr Top Microbiol Immunol; 1997; 224():103-12. PubMed ID: 9308233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of phosphatidylinositol-3-kinase causes cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism.
    Gottschalk AR; Doan A; Nakamura JL; Haas-Kogan DA; Stokoe D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1183-8. PubMed ID: 15752900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
    Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
    J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators.
    Johnson AM; Kartha CC
    Growth Factors; 2014 Apr; 32(2):53-62. PubMed ID: 24580070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
    Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
    J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
    Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase.
    Jeay S; Sonenshein GE; Kelly PA; Postel-Vinay MC; Baixeras E
    Endocrinology; 2001 Jan; 142(1):147-56. PubMed ID: 11145577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.